Literature DB >> 25398895

Synthesis, biophysical properties and biological activity of second generation antisense oligonucleotides containing chiral phosphorothioate linkages.

W Brad Wan1, Michael T Migawa2, Guillermo Vasquez2, Heather M Murray2, Josh G Nichols2, Hans Gaus2, Andres Berdeja2, Sam Lee2, Christopher E Hart2, Walt F Lima2, Eric E Swayze2, Punit P Seth2.   

Abstract

Bicyclic oxazaphospholidine monomers were used to prepare a series of phosphorothioate (PS)-modified gapmer antisense oligonucleotides (ASOs) with control of the chirality of each of the PS linkages within the 10-base gap. The stereoselectivity was determined to be 98% for each coupling. The objective of this work was to study how PS chirality influences biophysical and biological properties of the ASO including binding affinity (Tm), nuclease stability, activity in vitro and in vivo, RNase H activation and cleavage patterns (both human and E. coli) in a gapmer context. Compounds that had nine or more Sp-linkages in the gap were found to be poorly active in vitro, while compounds with uniform Rp-gaps exhibited activity very similar to that of the stereo-random parent ASOs. Conversely, when tested in vivo, the full Rp-gap compound was found to be quickly metabolized resulting in low activity. A total of 31 ASOs were prepared with control of the PS chirally of each linkage within the gap in an attempt to identify favorable Rp/Sp positions. We conclude that a mix of Rp and Sp is required to achieve a balance between good activity and nuclease stability.
© The Author(s) 2014. Published by Oxford University Press on behalf of Nucleic Acids Research.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25398895      PMCID: PMC4267618          DOI: 10.1093/nar/gku1115

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  43 in total

1.  RNA interference in mammalian cells by chemically-modified RNA.

Authors:  Dwaine A Braasch; Susan Jensen; Yinghui Liu; Kiran Kaur; Khalil Arar; Michael A White; David R Corey
Journal:  Biochemistry       Date:  2003-07-08       Impact factor: 3.162

2.  Crystal structures of RNase H bound to an RNA/DNA hybrid: substrate specificity and metal-dependent catalysis.

Authors:  Marcin Nowotny; Sergei A Gaidamakov; Robert J Crouch; Wei Yang
Journal:  Cell       Date:  2005-07-01       Impact factor: 41.582

Review 3.  Stereocontrolled synthesis of oligonucleotide analogs containing chiral internucleotidic phosphorus atoms.

Authors:  Natsuhisa Oka; Takeshi Wada
Journal:  Chem Soc Rev       Date:  2011-07-01       Impact factor: 54.564

4.  Stability of stereoregular oligo(nucleoside phosphorothioate)s in human plasma: diastereoselectivity of plasma 3'-exonuclease.

Authors:  M Koziołkiewicz; M Wójcik; A Kobylańska; B Karwowski; B Rebowska; P Guga; W J Stec
Journal:  Antisense Nucleic Acid Drug Dev       Date:  1997-02

5.  Pharmacokinetics of phosphorothioate antisense oligodeoxynucleotides.

Authors:  R S Geary; R Z Yu; A A Levin
Journal:  Curr Opin Investig Drugs       Date:  2001-04

6.  Stereodependent inhibition of plasminogen activator inhibitor type 1 by phosphorothioate oligonucleotides: proof of sequence specificity in cell culture and in vivo rat experiments.

Authors:  W J Stec; C S Cierniewski; A Okruszek; A Kobylańska; Z Pawłowska; M Koziołkiewicz; E Pluskota; A Maciaszek; B Rebowska; M Stasiak
Journal:  Antisense Nucleic Acid Drug Dev       Date:  1997-12

7.  Influence of diastereomeric ratios of deoxyribonucleoside phosphoramidites on the synthesis of phosphorothioate oligonucleotides.

Authors:  Z S Cheruvallath; H Sasmor; D L Cole; V T Ravikumar
Journal:  Nucleosides Nucleotides Nucleic Acids       Date:  2000-03       Impact factor: 1.381

8.  Solid-phase synthesis of stereoregular oligodeoxyribonucleoside phosphorothioates using bicyclic oxazaphospholidine derivatives as monomer units.

Authors:  Natsuhisa Oka; Mika Yamamoto; Terutoshi Sato; Takeshi Wada
Journal:  J Am Chem Soc       Date:  2008-11-26       Impact factor: 15.419

9.  Structural requirements at the catalytic site of the heteroduplex substrate for human RNase H1 catalysis.

Authors:  Walt F Lima; Josh G Nichols; Hongjiang Wu; Thazha P Prakash; Mike T Migawa; Tadensz K Wyrzykiewicz; Balkrishen Bhat; Stanley T Crooke
Journal:  J Biol Chem       Date:  2004-06-17       Impact factor: 5.157

10.  Inhibition of deoxyribonucleases by phosphorothioate groups in oligodeoxyribonucleotides.

Authors:  S Spitzer; F Eckstein
Journal:  Nucleic Acids Res       Date:  1988-12-23       Impact factor: 16.971

View more
  22 in total

Review 1.  Antisense technology: an overview and prospectus.

Authors:  Stanley T Crooke; Brenda F Baker; Rosanne M Crooke; Xue-Hai Liang
Journal:  Nat Rev Drug Discov       Date:  2021-03-24       Impact factor: 84.694

Review 2.  Therapeutic nucleic acids: current clinical status.

Authors:  Kannan Sridharan; Nithya Jaideep Gogtay
Journal:  Br J Clin Pharmacol       Date:  2016-06-03       Impact factor: 4.335

3.  Control of phosphorothioate stereochemistry substantially increases the efficacy of antisense oligonucleotides.

Authors:  Naoki Iwamoto; David C D Butler; Nenad Svrzikapa; Susovan Mohapatra; Ivan Zlatev; Dinah W Y Sah; Stephany M Standley; Genliang Lu; Luciano H Apponi; Maria Frank-Kamenetsky; Jason Jingxin Zhang; Chandra Vargeese; Gregory L Verdine
Journal:  Nat Biotechnol       Date:  2017-08-21       Impact factor: 54.908

Review 4.  Antisense technology: A review.

Authors:  Stanley T Crooke; Xue-Hai Liang; Brenda F Baker; Rosanne M Crooke
Journal:  J Biol Chem       Date:  2021-02-16       Impact factor: 5.157

5.  Investigating discovery strategies and pharmacological properties of stereodefined phosphorodithioate LNA gapmers.

Authors:  Jörg Duschmalé; Adrian Schäublin; Erik Funder; Steffen Schmidt; Łukasz J Kiełpiński; Helle Nymark; Klaus Jensen; Troels Koch; Martina Duschmalé; Erich Koller; Marianne Ravn Møller; Simone Schadt; Christophe Husser; Andreas Brink; Sabine Sewing; Tanja Minz; Jesper Wengel; Konrad Bleicher; Meiling Li
Journal:  Mol Ther Nucleic Acids       Date:  2022-06-22       Impact factor: 10.183

6.  Stereochemical bias introduced during RNA synthesis modulates the activity of phosphorothioate siRNAs.

Authors:  Hartmut Jahns; Martina Roos; Jochen Imig; Fabienne Baumann; Yuluan Wang; Ryan Gilmour; Jonathan Hall
Journal:  Nat Commun       Date:  2015-03-06       Impact factor: 14.919

7.  Electronic Structures of LNA Phosphorothioate Oligonucleotides.

Authors:  Henrik G Bohr; Irene Shim; Cy Stein; Henrik Ørum; Henrik F Hansen; Troels Koch
Journal:  Mol Ther Nucleic Acids       Date:  2017-06-01       Impact factor: 8.886

8.  Structural basis for the recognition of sulfur in phosphorothioated DNA.

Authors:  Guang Liu; Wencheng Fu; Zhenyi Zhang; Yao He; Hao Yu; Yuli Wang; Xiaolei Wang; Yi-Lei Zhao; Zixin Deng; Geng Wu; Xinyi He
Journal:  Nat Commun       Date:  2018-11-08       Impact factor: 14.919

9.  Site-specific Incorporation of 2',5'-Linked Nucleic Acids Enhances Therapeutic Profile of Antisense Oligonucleotides.

Authors:  Thazha P Prakash; Jinghua Yu; Wen Shen; Cheryl Li De Hoyos; Andres Berdeja; Hans Gaus; Xue-Hai Liang; Stanley T Crooke; Punit P Seth
Journal:  ACS Med Chem Lett       Date:  2021-04-05       Impact factor: 4.632

10.  Refining LNA safety profile by controlling phosphorothioate stereochemistry.

Authors:  Erik Daa Funder; Nanna Albæk; Annie Moisan; Sabine Sewing; Troels Koch
Journal:  PLoS One       Date:  2020-06-12       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.